• Profile
Close

Autoimmune hypercalcemia due to autoantibodies against the calcium-sensing receptor

Journal of Clinical Endocrinology & Metabolism May 24, 2020

Miñambres I, Corcoy R, Weetman AP, et al. - In the present study, the researchers sought to describe two patients in whom the presence of autoimmune hypocalciuric hypercalcemia (AHH) was suspected and to evaluate the patients for the presence of calcium-sensing receptor (CaSR) antibodies. CaSR antibodies were identified and characterized by immunoprecipitation assays, CaSR peptide ELISAs, and functional assays based on the calcium-stimulated accumulation of inositol-1-phosphate in a mammalian cell line expressing the CaSR. According to results, both of the patients had an acquired form of hypocalciuric hypercalcemia. Patients with an acquired biochemical pattern of PTH-dependant hypocalciuric hypercalcemia, particularly those with other concomitant autoimmune diseases, should be suspected of having AHH. Diagnosis by detecting CaSR antibodies can help improve the characterization of this condition, which is probably underreported.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay